The American Journal of Gastroenterology

Is irritable bowel syndrome more than just a gastroenterologist's problem?
pp. 943-945(3)
Author: Alpers, D.H.

''I think you have pancreatic cancer but I can't prove it yet''
pp. 945-946(2)
Author: Affronti, J.

Colonoscopic gamble
pp. 946-947(2)
Author: Plumeri, P.A.

Medical-legal risks of incident cancers after clearing colonoscopy
pp. 952-957(6)
Authors: Rex, D.K.; Bond, J.H.; Feld, A.D.

A critical approach to noncardiac chest pain: pathophysiology, diagnosis, and treatment
pp. 958-968(11)
Authors: Fang, J.; Bjorkman, D.

Stability of gastric secretory inhibition during 6-month treatment with omeprazole in patients with gastroesophageal reflux disease
pp. 969-974(6)
Authors: Tefera, S.; Gunnar Hatlebakk, J.; Berstad, A.

Esophageal pH monitoring: are you sure that the electrode is properly placed?
pp. 975-978(4)
Authors: Mones, J.; Clave, P.; Mearin, F.

Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial
pp. 979-983(5)
Authors: El-Serag, H.B.; Lee, P.; Buchner, A.; Inadomi, J.M.; Gavin, M.; McCarthy, D.M.

The ringed esophagus: histological features of GERD
pp. 984-989(6)
Authors: Morrow, J.B.; Vargo, J.J.; Goldblum, J.R.; Richter, J.E.

Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence
pp. 990-996(7)
Authors: Morris, C.D.; Armstrong, G.R.; Bigley, G.; Green, H.; Attwood, S.E.A.

Effect of small intestinal nutrient infusion on appetite, gastrointestinal hormone release, and gastric myoelectrical activity in young and older men
pp. 997-1007(11)
Authors: MacIntosh, C.G.; Horowitz, M.; Verhagen, M.A.M.T.; Smout, A.J.P.M.; Wishart, J.; Morris, H.; Goble, E.; Morley, J.E.; Chapman, I.M.

Helicobacter pylori vacA, iceA, and cagA status and pattern of gastritis in patients with malignant and benign gastroduodenal disease
pp. 1008-1013(6)
Authors: Miehlke, S.; Yu, J.; Schuppler, M.; Frings, C.; Kirsch, C.; Negraszus, N.; Morgner, A.; Stolte, M.; Ehninger, G.; Bayerdorffer, E.

Helicobacter pylori infection and serum ferritin: a population-based study among 1806 adults in Germany
pp. 1014-1018(5)
Authors: Berg, G.; Bode, G.; Blettner, M.; Boeing, H.; Brenner, H.

Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis
pp. 1019-1027(9)
Authors: Goldstein, J.L.; Correa, P.; Zhao, W.W.; Burr, A.M.; Hubbard, R.C.; Verburg, K.M.; Geis, G.S.

Intragastric acidification reduces the occurrence of false-negative urea breath test results in patients taking a proton pump inhibitor
pp. 1028-1032(5)
Authors: Chey, W.D.; Chathadi, K.V.; Montague, J.; Ahmed, F.; Murthy, U.

Psychological distress is linked to gastrointestinal symptoms in diabetes mellitus
pp. 1033-1038(6)
Authors: Talley, N.J.; Bytzer, P.; Hammer, J.; Young, L.; Jones, M.; Horowitz, M.

Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus
pp. 1039-1046(8)
Authors: Xia, H.H.; Talley, N.J.; Kam, E.P.Y.; Young, L.J.; Hammer, J.; Horowitz, M.

Reproducibility of gastric barostat studies in healthy controls and in dyspeptic patients
pp. 1047-1053(7)
Authors: Sarnelli, G.; Vos, R.; Cuomo, R.; Janssens, J.; Tack, J.

Diagnostic accuracy of Simpson atherectomy catheter biopsy in detecting pancreaticobiliary malignancy
pp. 1054-1058(5)
Authors: Kaufman, D.; Widlus, D.; Lazinger, M.; Didolkar, M.; Kumar, D.; Dutta, S.K.

Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis
pp. 1059-1066(8)
Authors: Kaya, M.; Petersen, B.T.; Angulo, P.; Baron, T.H.; Andrews, J.C.; Gostout, C.J.; Lindor, K.D.

Nonsurgical management of ruptured pseudoaneurysm in patients with hepatobiliary pancreatic diseases
pp. 1067-1071(5)
Authors: Okuno, A.; Miyazaki, M.; Ito, H.; Ambiru, S.; Yoshidome, H.; Shimizu, H.; Nakagawa, K.; Shimizu, Y.; Nukui, Y.; Nakajima, N.

The irritable bowel syndrome and psychiatric disorders in the community: is there a link?
pp. 1072-1079(8)
Authors: Talley, N.J.; Howell, S.; Poulton, R.

Successful and sustained treatment of chronic radiation proctitis with antioxidant vitamins E and C
pp. 1080-1084(5)
Authors: Kennedy, M.; Bruninga, K.; Mutlu, E.A.; Losurdo, J.; Choudhary, S.; Keshavarzian, A.

Neutrophil and eosinophil granule proteins as markers of response to local prednisolone treatment in distal ulcerative colitis and proctitis
pp. 1085-1090(6)
Authors: Sangfelt, P.; Carlson, M.; Thorn, M.; Loof, L.; Raab, Y.

Usefulness of colonoscopy with biopsy in the evaluation of patients with chronic diarrhea
pp. 1091-1095(5)
Authors: Shah, R.J.; Fenoglio-Preiser, C.; Bleau, B.L.; Giannella, R.A.

Macroamylasemia in patients with celiac disease
pp. 1096-1100(5)
Authors: Rabsztyn, A.; Green, P.H.R.; Berti, I.; Fasano, A.; Perman, J.A.; Horvath, K.

Occupational mortality from inflammatory bowel disease in the United States 1991-1996
pp. 1101-1105(5)
Authors: Cucino, C.; Sonnenberg, A.

Deficiency of colonic telomerase in ulcerative colitis
pp. 1106-1112(7)
Authors: Usselmann, B.; Newbold, M.; Morris, A.G.; Nwokolo, C.U.

The prevalence of celiac disease autoantibodies in patients with systemic lupus erythematosus
pp. 1113-1115(3)
Authors: Rensch, M.J.; Szyjkowski, R.; Shaffer, R.T.; Fink, S.; Kopecky, C.; Grissmer, L.; Enzenhauer, R.; Kadakia, S.

The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study
pp. 1116-1122(7)
Authors: Bernstein, C.N.; Blanchard, J.F.; Rawsthorne, P.; Yu, N.

Appendectomy protects against the development of ulcerative colitis and reduces its recurrence: results of a multicenter case-controlled study in Japan
pp. 1123-1126(4)
Authors: Naganuma, M.; Iizuka, B.; Torii, A.; Ogihara, T.; Kawamura, Y.; Ichinose, M.; Kojima, Y.; Hibi, T.; Tokyo,

The IBD1 locus for susceptibility to Crohn's disease has a greater impact in Ashkenazi Jews with early onset disease
pp. 1127-1132(6)
Authors: Akolkar, P.N.; Gulwani-Akolkar, B.; Lin, X.; Zhou, Z.; Daly, M.; Katz, S.; Levine, J.; Present, D.; Gelb, B.; Desnick, R.; Mayer, L.; Silver, J.

Selective recall of gastrointestinal-sensation words: evidence for a cognitive-behavioral contribution to irritable bowel syndrome
pp. 1133-1138(6)
Authors: Gibbs-Gallagher, N.; Palsson, O.S.; Levy, R.L.; Meyer, K.; Drossman, D.A.; Whitehead, W.E.

Abdominal wall muscle activity in irritable bowel syndrome with bloating
pp. 1139-1142(4)
Authors: McManis, P.G.; Newall, D.; Talley, N.J.

Efficacy of high-dose interferon in combination with ribavirin in patients with chronic hepatitis C resistant to interferon alone
pp. 1143-1149(7)
Authors: Min, A.D.; Jones, J.L.; Esposito, S.; Lebovics, E.; Jacobson, I.M.; Klion, F.M.; Goldman, I.S.; Geders, J.M.; Tobias, H.; Bodian, C.; Bodenheimer, H.C.

The utility of rifampin in diagnosing Gilbert's syndrome
pp. 1150-1154(5)
Authors: Divakara Murthy, G.; Byron, D.; Shoemaker, D.; Visweswaraiah, H.; Pasquale, D.

Effect of transjugular intrahepatic portosystemic shunt formation on portal hypertensive gastropathy and gastric circulation
pp. 1155-1159(5)
Authors: Mezawa, S.; Homma, H.; Ohta, H.; Masuko, E.; Doi, T.; Miyanishi, K.; Takada, K.; Kukitsu, T.; Sato, T.; Niitsu, Y.

Hepatocellular carcinoma in primary biliary cirrhosis: similar incidence to that in hepatitis C virus-related cirrhosis
pp. 1160-1163(4)
Authors: Caballera, L.; Pares, A.; Castells, A.; Gines, A.; Bru, C.; Rodes, J.

Treatment of cholangiocarcinoma complicating primary sclerosing cholangitis: the Mayo Clinic experience
pp. 1164-1169(6)
Authors: Kaya, M.; de Groen, P.C.; Angulo, P.; Nagorney, D.M.; Gunderson, L.L.; Gores, G.J.; Haddock, M.G.; Lindor, K.D.

Efficacy of interferon for chronic hepatitis C virus-related hepatitis in kidney transplant candidates on hemodialysis: results after transplantation
pp. 1170-1177(8)
Authors: Casanovas-Taltavull, T.; Baliellas, C.; Benasco, C.; Serrano, T.; Casanova, A.; Perez, J.L.; Guerrero, L.; Gonzalez, M.T.; Andres, E.; Gil-Vernet, S.; Casais, L.A.

Association of HLA-DR genes with mild idiopathic adulthood biliary ductopenia
pp. 1178-1182(5)
Authors: Garca-Jimenez, M.E.; Quiroga, J.A.; Gutierrez, M.L.; Pardo, M.; Carreno, V.

The metabolism of nicotinamide in human liver cirrhosis: a study on N-methylnicotinamide and 2-pyridone-5-carboxamide production
pp. 1183-1187(5)
Authors: Pumpo, R.; Sarnelli, G.; Spinella, A.; Budillon, G.; Cuomo, R.

Correlation of mutational analysis to clinical features in Taiwanese patients with Gilbert's syndrome
pp. 1188-1193(6)
Authors: Hsieh S.-Y.,; Wu, Y.; Lin, D.; Chu, C.; Wu, M.; Liaw, Y.

Serum xanthine oxidase in human liver disease
pp. 1194-1199(6)
Authors: Battelli, M.G.; Musiani, S.; Valgimigli, M.; Gramantieri, L.; Tomassoni, F.; Bolondi, L.; Stirpe, F.

Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis
pp. 1200-1204(5)
Authors: Nair, S.; Cope, K.; Terence, R.H.; Diehl, A.M.

Relationship between pre-TIPS liver perfusion by the portal vein and the incidence of post-TIPS chronic hepatic encephalopathy
pp. 1205-1209(5)
Authors: Hassoun, Z.; Deschenes, M.; Lafortune, M.; Dufresne, M.; Perreault, P.; Lepanto, L.; Gianfelice, D.; Bui, B.; Pomier-Layrargues, G.

Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis
pp. 1210-1216(7)
Authors: Lee, W.; Lin H.-C.,; Yang, Y.; Hou, M.; Lee, F.; Chang, F.; Lee, S.

Effects of high-volume plasmapheresis on ammonia, urea, and amino acids in patients with acute liver failure
pp. 1217-1223(7)
Authors: Clemmesen, J.O.; Kondrup, J.; Nielsen, L.B.; Larsen, F.S.; Ott, P.

Understanding the pathogenesis of autoimmune hepatitis
pp. 1224-1231(8)
Author: Czaja, A.J.

Spontaneous bacterial peritonitis-in-hospital mortality, predictors of survival, and health care costs from 1988 to 1998
pp. 1232-1236(5)
Authors: Thuluvath, P.J.; Morss, S.; Thompson, R.

Factors predicting interferon treatment response in patients with chronic hepatitis C: late viral clearance does not preclude a sustained response
pp. 1237-1242(6)
Authors: Ebeling, F.; Lappalainen, M.; Vuoristo, M.; Nuutinen, H.; Leino, R.; Karvonen, A.; Lehtola, J.; Julkunen, R.; Pohjanpelto, P.; Farkkila, M.

Prognostic factors after hepatic resection for hepatocellular carcinoma with hepatitis C viral infection: univariate and multivariate analysis
pp. 1243-1250(8)
Authors: Hanazaki, K.; Kajikawa, S.; Koide, N.; Adachi, W.; Amano, J.

Long-term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function
pp. 1251-1255(5)
Authors: Madrid, A.M.; Hurtado, C.; Venegas, M.; Cumsille, F.; Defilippi, C.

An audit of the utility of in-patient fecal occult blood testing
pp. 1256-1260(5)
Authors: Sharma, V.K.; Komanduri, S.; Nayyar, S.; Headly, A.; Modlinger, P.; Metz, D.C.; Verghese, V.J.; Wanahita, A.; Go, M.F.; Howden, C.W.

Possible role of telomerase activation in the multistep tumor progression of periampullary lesions in patients with familial adenomatous polyposis
pp. 1261-1265(5)
Authors: Mizumoto, K.; Ogawa, Y.; Niiyama, H.; Nagai, E.; Sato, N.; Urashima, T.; Matsumoto, T.; Iida, M.; Tanaka, M.

X-ray tube
pp. 1273-1273(1)
Author: Kravetz, R.E.

Postinfantile giant cell hepatitis complicating ulcerative colitis: a case report and review of the literature
pp. 1274-1277(4)
Authors: Labowitz, J.; Finklestein, S.; Rabinovitz, M.

Massive progression of diffuse hepatic lymphangiomatosis after liver resection and rapid deterioration after liver transplantation
pp. 1278-1281(4)
Authors: Datz, C.; Graziadei, I.W.; Dietze, O.; Jaschke, W.; Konigsrainer, A.; Sandhofer, F.; Margreiter, R.

Generalized intestinal dysmotility in a patient with syringomyelia
pp. 1282-1285(4)
Authors: Lacy, B.E.; Zayat, E.; Crowell, M.D.

A homozygous missense mutation in the tyrosine kinase domain of the RET proto-oncogene in an infant with total intestinal aganglionosis
pp. 1286-1291(6)
Authors: Shimotake, T.; Go, S.; Inoue, K.; Tomiyama, H.; Iwai, N.

Asymptomatic nonpathological persistent elevation of pancreatic enzymes: an inherited disorder?²
pp. 1292-1293(2)
Authors: Kumar, K.S.; Pitchumoni, C.S.

''Germ warfare'' for ulcerative colitis?¹
pp. 1293-1294(2)
Authors: Bahrani, O.; Flemmer, M.

Endoscopic removal of colonic lipomas
pp. 1295-1296(2)
Authors: Stone, C.; Weber, H.C.

Response to Drs. Stone and Weber
pp. 1296-1297(2)
Authors: Yarze, J.C.; Chase, M.P.; Solis, O.G.

Re: Liu et al.-estrogen receptor status in inoperable hepatocellular carcinoma
pp. 1297-1297(1)
Authors: Chow, P.K.H.; Hung, H.; Soo, K.C.

Response to Drs. Chow, Hung, and Soo
pp. 1297-1298(2)
Authors: Liu C.-L.,; Ng, I.O.; Fan, S.

Diagnosis of Helicobacter pylori infection with a stool assay: is it useful after eradication treatment?
pp. 1298-1299(2)
Authors: Archimandritis, A.; Giontzis, A.; Kourtesas, D.; Tzivras, M.; Smilakou, S.; Davaris, P.

Subsequent loss of the proliferated bile ductules in fulminant hepatitis in childhood-isn't it caused by apoptosis?
pp. 1299-1300(2)
Authors: Kunimura, T.; Ooike, N.; Sasajima, Y.; Ishikawa, Y.; Inagaki, T.; Morohoshi, T.

Cataflam-induced esophageal ulceration
pp. 1300-1301(2)
Authors: Isler, M.; Bahceci, M.

Thrombotic complications in inflammatory bowel disease: a multifactorial etiology
pp. 1301-1302(2)
Authors: Papa, A.; de Stefano, V.; Danese, S.; Gasbarrini, A.; Gasbarrini, G.

Endosonographic features of Brunner's gland hamartoma: location within the fourth echolayer?
pp. 1302-1303(2)
Authors: Matsushita, M.; Takakuwa, H.; Nishio, A.

Dry cough and optic neuritis: two rare complications of interferon α treatment in chronic viral hepatitis
pp. 1303-1304(2)
Authors: Isler, M.; Akhan, G.; Bardak, Y.; Akkaya, A.

Transmission of hepatitis C through tattooing in a United States prison
pp. 1304-1305(2)
Authors: Tsang, T.H.F.; Horowitz, E.; Vugia, D.J.

Treatment of severe esophageal Crohn's disease with thalidomide
pp. 1305-1306(2)
Authors: Ginsburg, P.M.; Hanan, I.; Ehrenpreis, E.D.

Exacerbation of inflammatory bowel disease associated with use of celecoxib
pp. 1306-1308(3)
Author: Bonner, G.F.

Therapeutic experience of hyperbaric oxygenation in entero-Behcet syndrome
pp. 1308-1309(2)
Authors: Kume, K.; Hashiba, T.; Yoshikawa, I.; Kanda, K.; Narita, R.; Otsuki, M.

A contented colon
pp. 1309-1309(1)
Author: Kirsch, M.

Percutaneous endoscopic gastrostomy and stomal bilious leakage-another management option?
pp. 1309-1310(2)
Authors: Yarze, J.C.; Herlihy, K.J.

Hepatic failure and encephalopathy attributed to an interaction between acetaminophen and rifampicin
pp. 1310-1311(2)
Authors: Stephenson, I.; Qualie, M.; Wiselka, M.J.

Angioedema after interferon therapy for chronic hepatitis C
pp. 1311-1312(2)
Authors: Ohmoto, K.; Yamamoto, S.

Pylephlebitis-diagnosis and management
pp. 1312-1313(2)
Authors: Singh, P.; Yadav, N.; Visvalingam, V.; Indaram, A.; Bank, S.

Human pituitary tumor transforming gene 1 (hPTTG1) in gastric mucosal tissues
pp. 1313-1314(2)
Authors: Yamada, M.; Asanuma, K.; Yagihashi, A.; Nakamura, M.; Kameshima, H.; Kobayashi, D.; Watanabe, N.

How important are the disturbances of lower gastrointestinal bowel habits in diabetic outpatients?
pp. 1314-1316(3)
Authors: Celik, A.F.; Osar, Z.; Damci, T.; Pamuk, O.N.; Pamuk, G.E.; Ilkova, H.

Addenda
pp. 1319-1319(1)

Addenda
pp. 1319-1319(1)